GlassScriptPhysician profile
Omar Kayaleh
NPI 1407830193
$4,164.77
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $3,435 · 2021: $16.00 · 2023: $117 · 2024: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,337.00 | 2020-2023 | Imfinzi |
| Incyte Corporation | $1,215.00 | 2020 | |
| Medtronic, INC. | $168.32 | 2024 | Signia |
| Sanofi-Aventis U.S. LLC | $116.23 | 2024 | |
| Angiodynamics, INC. | $103.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.64 | 2024 | Fruzaqla |
| Intera Oncology, INC | $78.13 | 2024 | Intera |
| Biocompatibles, INC. | $35.33 | 2019 | |
| Genentech USA, INC. | $16.00 | 2021 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Kayaleh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.